KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Liabilities and Shareholders Equity (2019 - 2025)

Historic Liabilities and Shareholders Equity for Hims & Hers Health (HIMS) over the last 7 years, with Q3 2025 value amounting to $2.2 billion.

  • Hims & Hers Health's Liabilities and Shareholders Equity rose 27082.0% to $2.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.7 billion, marking a year-over-year increase of 18955.29%. This contributed to the annual value of $707.5 million for FY2024, which is 6037.2% up from last year.
  • According to the latest figures from Q3 2025, Hims & Hers Health's Liabilities and Shareholders Equity is $2.2 billion, which was up 27082.0% from $1.9 billion recorded in Q2 2025.
  • Over the past 5 years, Hims & Hers Health's Liabilities and Shareholders Equity peaked at $2.2 billion during Q3 2025, and registered a low of $345.9 million during Q1 2021.
  • Its 5-year average for Liabilities and Shareholders Equity is $626.7 million, with a median of $420.1 million in 2021.
  • Per our database at Business Quant, Hims & Hers Health's Liabilities and Shareholders Equity crashed by 1289.73% in 2022 and then surged by 29075.59% in 2025.
  • Hims & Hers Health's Liabilities and Shareholders Equity (Quarter) stood at $420.6 million in 2021, then fell by 12.9% to $366.3 million in 2022, then increased by 20.43% to $441.2 million in 2023, then skyrocketed by 60.37% to $707.5 million in 2024, then surged by 215.64% to $2.2 billion in 2025.
  • Its Liabilities and Shareholders Equity stands at $2.2 billion for Q3 2025, versus $1.9 billion for Q2 2025 and $891.7 million for Q1 2025.